3221 - 3230 of 8620 Results
Title
Year
-
RESTRICTEDTitle: Correction to Conversion of Quinazoline Modulators from Inhibitors to Activators of β-GlucocerebrosidaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 62Issue #: 5Start Page: 2850End Page: 2850Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.9b00284Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b00284Citation Count: 0
-
RESTRICTEDTitle: Enduring questions in regenerative biology and the search for answersJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-023-05505-7Best OA location URL: https://www.nature.com/articles/s42003-023-05505-7.pdfCitation Count: 0
-
OPENTitle: Genomics transformer for diagnosing Parkinson's diseaseJournal Name: 2022 IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/bhi56158.2022.9926815Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942707Citation Count: 1
- Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a Cohort2021RESTRICTEDTitle: Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a CohortJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.634666Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.634666/pdfCitation Count: 3
- ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease2022RESTRICTEDTitle: ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s DiseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.848215Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.848215/pdfCitation Count: 17
-
RESTRICTEDTitle: Active Learning in Psychiatry Education: Current Practices and Future PerspectivesJournal Name: Frontiers in PsychiatryPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpsyt.2020.00211Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpsyt.2020.00211/pdfCitation Count: 19
-
RESTRICTEDTitle: Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experienceJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.653377Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.653377/pdfCitation Count: 19
-
RESTRICTEDTitle: Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 13Issue #: 3Start Page: 279End Page: 296Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-230021Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd230021?id=journal-of-parkinsons-disease%2Fjpd230021Citation Count: 3
-
RESTRICTEDTitle: Transient Receptor Potential Channels as an Emerging Target for the Treatment of Parkinson’s Disease: An Insight Into Role of Pharmacological InterventionsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2020.584513Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2020.584513/pdfCitation Count: 28
-
RESTRICTEDTitle: Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugsJournal Name: Frontiers in Bioengineering and BiotechnologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fbioe.2022.1035543Best OA location URL: https://www.frontiersin.org/articles/10.3389/fbioe.2022.1035543/pdfCitation Count: 7